General
MSD Malaysia launches dual-mechanism drug that significantly lowers LDL-C levels
 

MSD Malaysia launches dual-mechanism drug that significantly lowers LDL-C levels

Shared by:

 
MSD Malaysia recently announced the approval of ATOZET, a combination of ezetimibe and atorvastatin in Malaysia, at a media launch, held on 26 July. The once-daily combination tablet boasts a dual mechanism of action – treating two main sources of cholesterol in the blood and claims to reduce LDL-C levels by 27%.
 
today.mims.com
 
28 Jul 2017 - General